Aimed Bio to Host IR at KOSDAQ Connect 2026 - Business Update Focus with Limited Stock Impact


  • Aimed Bio will participate in KOSDAQ Connect 2026 on July 2, 2026 at the Korea Exchange Promotion Center, presenting its business status and holding a Q&A session for institutional investors, analysts, and media.
  • This IR event is a routine briefing co-sponsored by the Korea Exchange, Korea IR Service, and KOSDAQ Association. It does not involve any new capital raising or changes in share structure.
  • The disclosure contains no capital events such as share issuance, conversion price adjustments, or treasury stock transactions that would directly affect shareholder value.
  • [AI Summary]This filing represents a routine IR activity with no new fundraising or capital changes. The event is purely informational, with negligible impact on the stock price or shareholder value.

KOSDAQ Filing Information


  • Holding of Investor Relations Conference (IR)
  • Company: Aimed Bio (0009K0)
  • Submission: Aimed Bio Inc.
  • Under KRX KOSDAQ Market Division

  • Shares: 64,671,161
  • Price: 26,050 KRW
  • Market Cap: 1,684.7 B KRW